Closer collaboration between payers and researchers could result in better coverage policies and cost savings for payers and in more data for researchers, according to the FDA.
“Evidence generation serves payers’ most important mission — to improve their beneficiaries’ health,” the researchers wrote. “Although payers mainly accomplish this task through coverage of health care services and medical products, payers have a responsibility to participate in generating evidence that can help ensure the right patient gets the right treatment at the right time.”
The FDA researchers proposed several ways payers could better support clinical trials:
- Reducing administrative and financial barriers for members participating in clinical trials.
- Funding research that could result in cost savings for insurers.
- Engaging with medical devicemakers on evidence standards for coverage decisions.
- Making claims data more easily accessible for researchers.
Read the full article here.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.